(1)
Odierna, G. L.; Phillips, W. Targeting the Safety Factor for Neuromuscular Transmission to Treat Myasthenia Gravis: Safety Factor for Neuromuscular Transmission.
rrnmf
2023
,
4
(3).
https://doi.org/10.17161/rrnmf.v4i3.19543
.